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OBJECTIVES We sought to determine the pathogenetic predictors of collateral channels in a large cohort
of patients with coronary artery disease (CAD).
BACKGROUND The frequency distribution of collateral flow in patients with CAD is unknown. Only small
qualitative studies have investigated which factors influence the development of collateral
channels.
METHODS In 450 patients with one- to three-vessel CAD undergoing percutaneous transluminal
coronary angioplasty (PTCA), collateral flow was measured. A collateral flow index (CFI; no
unit) expressing collateral flow relative to normal anterograde flow was determined using
coronary wedge pressure or Doppler measurements through sensor-tipped PTCA guide
wires. Frequency distribution analysis of CFI and univariate and multivariate analyses of 32
factors, including gender, age, patient history, cardiovascular risk factors, medication and
coronary angiographic data, were performed.
RESULTS Two-thirds of the patients had a CFI 0.25 and 40% of patients had a CFI 0.15, but
only 10% of the patients had a recruitable CFI 0.4. By univariate analysis, the following
were predictors of CFI0.25: high levels of high-density lipoprotein cholesterol, the absence
of previous non–Q-wave myocardial infarction, angina pectoris during an exercise test,
angiographic indicators of severe CAD and the left circumflex or right coronary artery as the
collateral-receiving vessel. Percent diameter stenosis of the lesion undergoing PTCA was the
only independent predictor of a high CFI.
CONCLUSIONS This large clinical study of patients with CAD in whom collateral flow was quantitatively
assessed reveals that two-thirds of the patients do not have enough collateral flow to prevent
myocardial ischemia during coronary occlusion, and that coronary lesion severity is the only
independent pathogenetic variable related to collateral flow. (J Am Coll Cardiol 2001;38:
1872–8) © 2001 by the American College of Cardiology
The coronary collateral circulation is an alternative source of
blood supply to myocardium jeopardized by stenosis or
occlusion of a coronary vessel. A well-developed coronary
collateral circulation may have a considerable impact on the
prognosis of coronary artery disease (CAD) (1). So far, a
few pathogenetic factors have been consistently described as
influencing the development of coronary collateral channels.
Well-established factors positively determining the extent
of collateralization are the severity of coronary artery steno-
ses (2) and the duration of myocardial ischemic symptoms
(3,4). In contrast, there has been discordant data on the
influence of metabolic disorders on collateral channel de-
velopment, such as diabetes mellitus (5–7). The possible
relevance of cholesterol metabolism to the expansion of the
collateral circulation has been indicated only experimentally
(8). The presence of systemic hypertension has also been
suggested to influence the development of well-grown
collateral channels (9). Previous studies on the pathogenesis
of collateral channels in humans often lack sufficient patient
numbers or quantitative means for collateral channel assess-
ment, or both. Several studies have shown that assessing the
collateral circulation by intracoronary Doppler flow or
pressure wires, or both, is a precise method to determine
collateral blood flow in the clinical setting (10–12).
The purpose of this study of 450 patients with CAD was
to determine how often different levels of collateral flow
occur and to comprehensively elucidate the pathogenetic
factors that independently influence the development of the
coronary collateral network.
METHODS
Patients. In 450 patients (age 61  11 years) with one- to
three-vessel CAD and without Q-wave myocardial infarc-
tion, the coronary collateral circulation was measured quan-
titatively in one coronary artery undergoing percutaneous
transluminal coronary angioplasty (PTCA) because of
CAD-related symptoms. The patients included in this study
have been described in part elsewhere (11,13–19). These
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studies were approved by the local Ethics Committee, and
the patients gave written, informed consent to participate.
The patients were classified into two groups according to
an intracoronary, sensor-derived collateral flow index (CFI;
no unit) 0.25 or 0.25. The CFI expresses collateral flow
during coronary balloon occlusion relative to normal antero-
grade flow during vessel patency. A CFI 0.25 has been
demonstrated to be sufficient to prevent myocardial isch-
emia in a region supplied by an occluded coronary artery
(11).
Coronary angiography. The patients underwent left heart
catheterization, including biplane left ventricular angiogra-
phy and coronary angiography, for diagnostic purposes.
Coronary artery stenoses were assessed quantitatively as the
percent diameter reduction, using the guiding catheter for
calibration. The area at risk of myocardial infarction was
measured quantitatively from coronary angiograms as the
summed coronary artery branch lengths of the epicardial
vascular tree distal to the stenosis to be dilated in relation to
the branch lengths of the entire coronary artery tree (20).
This ratio represents the amount of myocardium distal to a
stenosis relative to the total amount of myocardium supplied
by the entire vessel. Aortic pressure was measured using the
guiding catheter during angioplasty.
Collateral channel assessment. Collateral channel assess-
ment was performed by four different methods in all
patients, whereby the principal end point of the study was
the functional measurement obtained by sensor-tipped
guide wires during vessel occlusion (i.e., recruitable collat-
eral flow).
Either the 0.014-in. (0.035-cm), intracoronary pressure,
sensor-tipped guide wire or the Doppler guide wire was
used during PTCA. The fiberoptic pressure guide wire
(WaveWire, Endosonics, Rancho Cordova, California; or
PressureWire, Radi Medical, Uppsala, Sweden) was set at
zero, calibrated, advanced through the guiding catheter,
normalized for aortic pressure at the ostium of the coronary
artery and positioned distal to the stenosis to be dilated. The
pressure-derived collateral flow index (CFIp; no unit) was
determined (n  328) by simultaneous measurement of
mean aortic pressure (Pao, mm Hg) and distal coronary
pressure at the end of 1-min balloon occlusion (Poccl, or
coronary wedge pressure, mm Hg). If not gauged simulta-
neously (n  120), central venous pressure (CVP, mm Hg)
was estimated at 5 mm Hg. The CFI was calculated as:
(Poccl  CVP)/(Pao  CVP) (11,21). The CFI values
computed by estimated CVP did not differ from those
calculated by measured CVP: 0.22  0.15 and 0.22  0.15,
respectively.
We have demonstrated that coronary wedge pressure is a
reliable measure of collateral flow in patients with left
ventricular end-diastolic pressure (LVEDP) 15 mm Hg
before vessel occlusion (22). Therefore, in the presence of
LVEDP15 mm Hg, intracoronary flow velocity measure-
ments were used to assess CFI. Velocity-derived CFI
(CFIv) measurements (n  217) were performed using a
0.014-in. Doppler guide wire with a 12-MHz, piezoelectric
crystal at its tip (FlowWire, Endosonics). In 192 patients,
simultaneous pressure and Doppler-derived CFI measure-
ments were performed. Validation of the Doppler wire has
been described previously (23). Velocity-derived CFI was
determined as the ratio of the flow velocity–time integral
distal to the occluded stenosis divided by the baseline flow
velocity–time integral obtained at the same site after PTCA
and after reactive hyperemia (11). Bi-directional flow veloc-
ity signals were added to obtain the total collateral flow
velocity. Pressure- and Doppler-derived methods for collat-
eral channel assessment have been validated previously
(11,12). If both pressure- and flow-derived CFIs were
determined in one patient, the average between CFIp and
CFIv was calculated to assess the CFI.
Myocardial ischemia during balloon occlusion was as-
sessed by the occurrence of angina pectoris and by a
simultaneously obtained intracoronary electrocardiogram
(ECG) (24). In the absence of ST-segment changes
0.1 mV during 1-min balloon occlusion, coronary collat-
eral channels were defined as sufficient or insufficient col-
lateral channels.
The degree of angiographic collateral flow was deter-
mined according to the extent of epicardial coronary artery
filling through collateral channels injected with a contrast
agent from the contralateral side before PTCA: 0  no
filling of the distal vessel; 1 small side branches filled; 2
major side branches filled; and 3  main vessel filled (2).
Statistical analysis. Univariate analysis of all 32 categorical
and continuous variables, with regard to the two study
groups or continuous CFI values, was performed using the
chi-square test, unpaired Student t test and linear regression
analysis, respectively. Multivariate analysis was performed
by multiple regression, testing all demographic, clinical,
hemodynamic and angiographic factors for their indepen-
dence as a predictor of CFI. The variables tested included
the following: age, gender, body mass index, mean blood
pressure, heart rate, left ventricular ejection fraction,
LVEDP, six cardiovascular risk factors (Table 1), seven
cardiovascular drugs (Table 1), serum lipids, previous non–
Q-wave myocardial infarction, treadmill exercise test results
obtained before invasive examination and six coronary
Abbreviations and Acronyms
CAD  coronary artery disease
CFI  collateral flow index
CVP  central venous pressure
LAD  left anterior descending coronary artery
LCx  left circumflex coronary artery
LVEDP  left ventricular end-diastolic pressure
Pao  aortic pressure
Poccl  occlusive pressure (coronary wedge pressure)
PTCA  percutaneous transluminal coronary
angioplasty
RCA  right coronary artery
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angiographic variables. Statistical significance was set at p
0.05. Data are presented as the mean value  SD.
RESULTS
Univariate analysis: clinical data. There was no statisti-
cally significant difference between the groups in terms of
gender, age, body mass index, mean blood pressure, heart
rate or left ventricular systolic function and filling pressure
(Table 1). Furthermore, there was no significant difference
in the cardiovascular risk profile or cardiovascular medical
therapy between patients with CFI 0.25 and those with
CFI 0.25 (Table 1). Total serum cholesterol showed a
trend toward higher values in the group with CFI 0.25
than in the group with CFI0.25 (p 0.09). High-density
lipoprotein (HDL) cholesterol was significantly lower in the
group with CFI 0.25 than in the group with CFI 0.25.
The ratio between total cholesterol and HDL cholesterol
was higher in patients with CFI 0.25 than in the patients
with CFI 0.25. There was no difference in the serum
low-density lipoprotein cholesterol and triglyceride levels
between the groups (Table 1).
Patients with previous nontransmural infarctions had a
lower CFI than did those without these infarctions, and
patients without angina pectoris during the treadmill exer-
cise test had a significantly lower CFI than did those with
chest pain (Table 2).
Univariate analysis: coronary angiographic data. Individ-
uals without chronic total coronary artery occlusions re-
vealed a lower CFI than did those with occlusions (Table 2).
Patients undergoing CFI measurement in the left anterior
descending coronary artery (LAD) had a lower CFI than
did those with left circumflex coronary artery (LCx) or right
coronary artery (RCA) CFI measurements (Table 2). There
were significant differences between the groups in percent
diameter stenosis of the lesion undergoing PTCA, in the
number of total coronary occlusions, in the number of
vessels affected by CAD, in the total number of stenoses and
in the area at risk of myocardial infarction (Table 3). Percent
diameter stenosis correlated directly with the CFI (Fig. 1).
Area at risk of myocardial infarction was directly and
significantly associated with the CFI (Fig. 2). When the
CFI was measured in the LAD, it occurred more frequently
in the group with CFI 0.25 than in the group with CFI
0.25 (Table 3).
Frequency distribution of collateral flow and collateral
channel assessment. The CFI distribution in our study
group is shown in Figure 3. On average, CFI was 0.22 
0.15. The CFI was 0.25 in 307 patients (68%) and 0.25
Table 1. Univariate Analysis: Clinical Characteristics
CFI <0.25
(n  307)
CFI >0.25
(n  143) p Value
Men 236 (77%) 109 (76%) NS
Age (years) 61  10 61  11 NS
Body mass index (kg/m2) 27  4 27  4 NS
Mean blood pressure, Pao (mm Hg) 95  15 96  16 NS
Heart rate (beats/min) 73  12 72  12 NS
LVEF (%) 65  11 66  11 NS
LVEDP (mm Hg) 14  7 13  6 NS
Cardiovascular risk factors
Diabetes mellitus 46 (15%) 24 (17%) NS
Systemic hypertension 157 (51%) 69 (48%) NS
Smoking 117 (38%) 69 (48%) NS
Obesity 61 (20%) 27 (19%) NS
Untreated hypercholesterolemia 55 (18%) 31 (22%) NS
Family history for CAD 101 (33%) 50 (35%) NS
Cardiovascular medication
ASA 252 (82%) 124 (87%) NS
Beta-blockers 178 (58%) 90 (63%) NS
Nitrates 117 (38%) 57 (40%) NS
Cholesterol-lowering drugs 101 (33%) 44 (31%) NS
ACE inhibitors 80 (26%) 30 (21%) NS
Calcium antagonists 52 (17%) 26 (18%) NS
Diuretics 28 (9%) 27 (19%) NS
Serum lipids
Cholesterol (mmol/l) 5.7  1.1 5.5  1.0 NS
HDL cholesterol (mmol/l) 1.2  0.3 1.3  0.5 0.02
LDL cholesterol (mmol/l) 3.4  1.0 3.3  1.0 NS
Total cholesterol/HDL cholesterol 5.1  1.8 4.8  1.9 0.03
Triglycerides (mmol/l) 2.0  1.5 1.9  1.5 NS
Data are presented as the number (%) of patients or mean value  SD.
ACE  angiotensin-converting enzyme; ASA  acetylsalicylic acid; CAD  coronary artery disease; CFI  collateral flow
index; HDL  high-density lipoprotein; LDL  low-density lipoprotein; LVEDP  left ventricular end-diastolic pressure;
LVEF  left ventricular ejection fraction; NS  not significant.
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in 143 patients (32%) (Table 3, Fig. 3). The mean CFI in
these groups was 0.14 0.07 and 0.38 0.14, respectively.
This distribution was consistent, irrespective of the method
of assessing CFI. The CFIv was 0.16 0.07 and 0.40 0.18,
whereas CFIp was 0.13 0.1 and 0.33 0.14, respectively, in
the two groups. Angina pectoris during balloon occlusion
occurred in 67% of patients with insufficient collateral channels
and in 42% of those with sufficient collateral channels (p 
0.0001). In the group of patients with insufficient collateral
flow, 84% of the patients developed ST-segment elevations
1 mm on the intracoronary ECG during balloon occlusion of
the artery, whereas only 26% did so in the group with sufficient
collateral flow (p  0.0001). The degree of angiographic
collateral flow (grades 0 to 3) differed significantly between the
two groups (Table 3).
Multivariate analysis. Multiple regression analysis with
CFI as the dependent variable revealed that the 32 clinical
and angiographic variables described in the Methods section
accounted for 32% of the CFI variability (p  0.0048).
Introducing all of the variables for collateral channel assess-
ment (Table 3), in addition to the clinical variables, into the
model yielded 95% of the independent variables accounting
for CFI variability. Using the clinical and angiographic
variables in the model, percent diameter stenosis of the
lesion undergoing CFI measurement (i.e., PTCA) was the
only independent predictor of a high CFI (p  0.0001).
Table 2. Univariate Analysis: Variables Related to Collateral Flow
Variable CFI p Value
Previous non–Q-wave myocardial infarction
Yes (n  50) 0.17  0.12
No (n  400) 0.23  0.15 0.01
Treadmill exercise test with angina pectoris
Yes 0.27  0.17
No 0.20  0.16 0.01
Presence of chronic total coronary occlusion
Yes 0.30  0.18
No 0.19  0.14  0.0001
Coronary arteries undergoing CFI measurement
LAD (n  255) 0.19  0.13
LCX (n  90) 0.25  0.16 0.0008*
RCA (n  105) 0.25  0.17 0.0003*
*Compared with LAD. Data are presented as the mean value  SD.
CFI collateral flow index; LAD left anterior descending coronary artery; LCx left circumflex coronary artery; RCA
right coronary artery.
Table 3. Univariate Analysis: Coronary Angiographic Data and Collateral Channel Assessment
CFI <0.25
(n  307)
CFI >0.25
(n  143) p Value
Coronary angiographic data
Percent diameter narrowing of stenosis 76  14 82  15  0.0001
No. of chronic total occlusions 35 (16%) 50 (35%)  0.0001
No. of vessels diseased 1.8  0.7 2.0  0.8 0.04
No. of stenoses 2.9  1.8 3.4  2 0.01
Area at risk of myocardial infarction 0.46  0.2 0.51  0.2 0.04
Vessel undergoing CFI measurement (i.e., PTCA)
LAD 185 (60%) 70 (49%) 0.03
LCx 61 (19%) 29 (20%) NS
RCA 65 (21%) 40 (28%) NS
Collateral assessment
CFI* 0.14  0.07 0.38  0.14  0.0001
CFIv (n  217) 0.16  0.07 0.40  0.18  0.0001
CFIp (n  328) 0.13  0.1 0.33  0.14  0.0001
Angina pectoris during PTCA 206 (67%) 60 (42%)  0.0001
Intracoronary ECG
Insufficient collateral flow 258 (84%) 37 (26%)  0.0001
Sufficient collateral flow 49 (16%) 106 (74%)  0.0001
Degree of angiographic collateral flow (0–3) 0.55  0.73 1.45  1.07  0.0001
*CFv or CFIp or average of both when measured simultaneously (n  112). Data are presented as the mean value  SD or
number (%) of patients.
CFIv  Doppler flow velocity-derived CFI; CFIp  pressure-derived CFI; ECG  electrocardiogram; PTCA 
percutaneous transluminal coronary angioplasty. Other abbreviations as in Table 2.
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DISCUSSION
The present analysis in 450 patients with CAD revealed
that a well-developed collateral circulation, as assessed
quantitatively, is pathogenetically influenced only by the
severity of coronary atherosclerosis. Collateral flow sufficient
to prevent myocardial ischemia during coronary occlusion
was found in only one-third of the patients.
Frequency distribution of collateral flow in humans. As
shown by Vanoverschelde et al. (25), in selected patients
with total coronary artery occlusions, in the absence of
myocardial infarction, collateral flow to the myocardial
region in need can be as high as 60% to 80% of normal
perfusion. Recent investigations in rather small groups have
revealed that well-developed collateral channels are present
in one-fourth to one-half of patients with CAD, and such
anastomoses have been defined to conduct 25% of the
normal blood flow to the occluded vascular area (10,26).
Using the same cut-off value of 25% collateral flow relative
to normal flow, the present study found that 32% of patients
had collateral channels sufficient to prevent myocardial
ischemia during brief coronary occlusions. This investiga-
tion is sufficiently powered to reliably document, for the first
time, to the best of our knowledge, the Poisson distribution
of collateral flow, with 40% of the patients having a CFI
0.15 and, at the higher end of the range, only 10%
of the patients (n  44) having a recruitable CFI 0.4
(Fig. 3).
Protective potential of collateral channels in humans.
The question may be raised as to whether the definition
used for sufficient collateral flow (i.e., CFI 0.25) is
reasonable. Pijls et al. (27) predicted absent ischemia cor-
rectly in all of 29 subjects with no ECG signs of ischemia
induced by 1- to 2-min coronary balloon occlusions, and in
our study, ischemia was predictable in 107 (75%) of 143
patients. Angina pectoris occurring during balloon occlusion
could be predicted much less reliably (i.e., in only 42%) in
patients with a CFI0.25. Regarding the clinical end point
of myocardial necrosis after revascularized acute coronary
thrombotic occlusion, Lee et al. (26) demonstrated that
patients with sufficient collateral flow were not free of it.
However, they also made it clear that among patients with
well-developed collateral channels, infarct size no longer
depended on how long it took to open the vessel, but rather
on how extensively the collateral channels were developed.
These findings are consistent with the concept introduced
20 years ago by Reimer et al. (28), who stated that infarct
size is a product of coronary occlusion time (in case of
sufficient collateral flow being a constant 0), the ischemic
area at risk of infarction and the inverse of collateral flow to
it. Aside from the apparent relationship between occlusion
duration and collateral flow, another relationship—that
between area at risk and “natural bypasses” to it—becomes
intuitively evident. Although the correctness of such a
relationship in which there is a declining area at risk (as the
Figure 1. Collateral flow index (CFI; no unit) versus percent diameter narrowing of the stenosis to be dilated. The CFI is higher in patients with more
severe coronary artery stenosis.
Figure 2. Collateral flow index (CFI; no unit) versus area at risk of
myocardial infarction. The CFI is higher in patients with a larger area at
risk of myocardial infarction distal to the stenosis to be dilated.
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dependent variable), as influenced by augmented collateral
flow, was not tested in our study, an additional hypothesis of
improved collateral channel development (as the dependent
variable), related to greater ischemic risk territories, was
verified by univariate analysis (Fig. 2).
Factors influencing collateral channel development in
humans. Closely related to the finding just discussed,
proximal stenosis location (i.e., a nominal variable for area at
risk of infarction) has been found to be an independent
variable related to recruitable collateral channels, aside from
stenosis severity and duration of angina pectoris (29).
Although our categories of proximal, mid and distal stenosis
location were perfectly associated (p  0.0001; data not
shown) with angiographically determined area at risk, the
relationship documented by Piek et al. (29) could not be
reproduced. This may be explained by the unexpected result
of our investigation that collateral flow to the LAD was
consistently lower than that to the LCx or RCA, although
it was the LCx and not the LAD with the lowest number of
proximally located stenoses (approximately one-third vs.
one-half in LAD vs. RCA, respectively; results not shown).
Percent diameter coronary artery narrowing—the only vari-
able consistently described as an independent predictor of
well-developed collateral channels (30,31)—was corrobo-
rated in our study. The fact that the presence of chronic
total occlusion was also linked to improved collateral flow
supports the finding of stenosis severity as a predictor of a
high CFI, biologically. Pathophysiologically, it is reasonable
that stenosis severity is the variable influencing preexisting,
likely ischemia-induced, small collateral channels to become
conductive anastomoses, because the perfusion pressure
gradient directed toward the blocked vascular area leads to
an increase in flow velocity and shear forces within the
preformed collateral channels, thus causing their dilation
and remodeling (32).
Inconsistently described pathogenetic factors related to
impaired collateral development are old age (33), female
gender (6), high heart rate (34), hypercholesterolemia (8),
systemic hypertension (9) and cardiovascular drugs such as
nitrates (29) and spironolactone (35). In our study, elevated
HDL cholesterol showed an association with a high CFI,
although it did not manifest itself as an independent
predictor. Accordingly, a history of hypercholesterolemia
was not related to impaired, recruitable collateral flow, nor
was the presence of any other cardiovascular risk factors.
This is reiterated here with regard to a recently published
study in which a group of patients with diabetes mellitus
had a worse degree of angiographic collateral flow than that
in the nondiabetic control group (6). Unfortunately, this
well-powered study did not angiographically measure the
recruitable collateral score, and more importantly, the only
variable constantly described to influence collateral channel
development—coronary stenosis severity—was estimated
visually, thus practically excluding it from suitable analysis.
Study limitations. Our study group is not representative of
all patients with CAD, because of a selection bias. Excluded
from the study were patients with myocardial infarction in
the vascular territory undergoing collateral flow measure-
ment. Patients with an extensively developed coronary
collateral network, which prevents myocardial ischemia,
even during exercise, do not suffer from angina pectoris and
therefore do not need to undergo coronary angiography.
Thus, the frequency of patients with CAD and extremely
well-adapted collateral flow to a myocardial area in need
may be underestimated.
Our study group consisted of a nonuniform group of
Figure 3. Frequency distribution (expressed as percentage of entire population) of pressure- and Doppler flow velocity-derived collateral flow index (CFI)
(no unit) in 450 patients with coronary artery disease. Sixty-eight percent of the patients had a CFI 0.25 (white-spotted columns), indicating collateral
flow insufficient to protect the myocardium from ischemia during coronary occlusion. Patients with a CFI 0.25 are indicated by the solid black columns.
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patients with variably severe CAD, 10% of whom had a
nontransmural myocardial infarction; these facts may have
confounded the interpretation of the data.
The duration of angina pectoris was not determined, so
this variable could not be used reliably for data analysis in
our study. Thus, this factor may have theoretically been
overlooked as predictor of well-developed collateral chan-
nels.
Conclusions. This large clinical study of patients with
CAD and quantitatively assessed collateral flow reveals that
two-thirds of the patients do not have enough collateral flow
to prevent myocardial ischemia during coronary occlusion,
and that coronary lesion severity is the only independent
pathogenetic variable related to collateral flow.
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